Stada Partners With Calliditas On Novel Budesonide Formulation

Deal Worth Over $100m Targets First European Approval For Orphan IgAN Treatment

 
• By David Wallace
  
Stada logo magnifying glass
Stada has partnered with Calliditas on its innovative budesonide formulation • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business